
Making complex medical information simple. Our AI-assisted articles break down the latest in health research, making it easy to understand and accessible to all. Every piece is reviewed by medical professionals to ensure accuracy and clarity.
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 247 | Subscribers | Read | sciencemyhealth.substack.com |
Curious about how many subscribers ScienceMyHealth has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over six million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Recent posts by this newsletter. Browse the email archive.
The U.S. Food and Drug Administration recently approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the treatment of pediatric and adult patients ...
GLP-1 receptor agonists are powerful medications used to treat obesity. These medicines, such as semaglutide, liraglutide, and tirzepatide, help people lose weight by reducing appetite and slowing how quickly food leaves the stomach. They h...
The U.S. Food and Drug Administration today is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they a...
## What is it prescribed for?
The writers behind this newsletter.
Making complex medical information simple. Our AI-assisted articles break down the latest in health research, making it easy to understand and accessible to all. Every piece is reviewed by medical professionals to ensure accuracy and clarity.
You can find recent issues that have been published by ScienceMyHealth on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to ScienceMyHealth, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch ScienceMyHealth as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact ScienceMyHealth using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like ScienceMyHealth. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.